Pentwater Capital Management
1
142M
1
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline Poseida Therapeutics Among the most successful fund investment fields, there are Biotechnology, Medical Device.
The important activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of more than 100 millions dollars.
The standard case for the fund is to invest in rounds with 9 partakers. Despite the Pentwater Capital Management, startups are often financed by Malin Corporation, Vivo Capital, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Rapha Capital Management, Perceptive Advisors.
The overall number of key employees were 1.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Biotechnology (1)
- Therapeutics (1)
- Genetics (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 36M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Poseida Therapeutics | 22 Apr 2019 | Biotechnology, Genetics, Therapeutics | Late Stage Venture | 142M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.